Mast cell deficient W/Wv mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis

被引:38
作者
Huang, M
Berry, J
Kandere, K
Lytinas, M
Karalis, K
Theoharides, TC
机构
[1] Tufts Univ, New England Med Ctr, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
[2] Tufts Univ, New England Med Ctr, Sch Med, Dept Biochem, Boston, MA 02111 USA
[3] Harvard Univ, Sch Med, Childrens Hosp, Div Endocrinol, Boston, MA USA
[4] Tufts Univ, Sch Med, Dept Med, New England Med Ctr, Boston, MA USA
来源
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY | 2002年 / 15卷 / 03期
关键词
arthritis; CRH; IL-6; mast cells; skin; stress;
D O I
10.1177/039463200201500314
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Corticotropin releasing hormone (CRH) and interleukin-6 (IL-6) are implicated in inflammatory diseases triggered by stress. Acute restraint stress increases serum IL-6 in the blood, but its source is not known. Our current study was carried out in order to determine the contribution of mast cells to stress-induced IL-6 release and to investigate skin CRH and vascular permeability in mice. W/W-v mast cell deficient and their wild type control +/+ mice were stressed in a plexiglass restraint chamber for 60 or 120 min. Serum corticosterone and IL-6 levels were measured. Other mice were injected with 99-Tchnetium gluceptate (Tc-99) and its extravastion, indicating vascular permeability, was determined along with CRH levels in the skin and knee joints. Acute stress increased serum IL-6 in mice, but was greatly inhibited in W/W-v mast cell deficient mice. Vascular permeability to 99Tc, as well as local CRH levels, were also increased by stress, but not in W/W-v mice. Findings from our current study suggest a link between mast cells and stress-related skin and joint inflammation and may explain initial events in psoriatic and rheumatoid arthritis.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 48 条
[1]   Human lymphocytes produce urocortin, but not corticotropin-releasing hormone [J].
Bamberger, CM ;
Wald, M ;
Bamberger, AM ;
Ergün, S ;
Beil, FU ;
Schulte, HM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) :708-711
[2]  
Boss B, 2000, Z RHEUMATOL, V59, P62
[3]   HUMAN SYNOVIAL MAST-CELL INVOLVEMENT IN RHEUMATOID-ARTHRITIS AND OSTEOARTHRITIS - RELATIONSHIP TO DISEASE TYPE, CLINICAL ACTIVITY, AND ANTIRHEUMATIC THERAPY [J].
BRIDGES, AJ ;
MALONE, DG ;
JICINSKY, J ;
CHEN, M ;
ORY, P ;
ENGBER, W ;
GRAZIANO, FM .
ARTHRITIS AND RHEUMATISM, 1991, 34 (09) :1116-1124
[4]  
Ceponis A, 1998, J RHEUMATOL, V25, P2304
[5]   SEMINARS IN MEDICINE OF THE BETH-ISRAEL-HOSPITAL, BOSTON - THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AND IMMUNE-MEDIATED INFLAMMATION [J].
CHROUSOS, GP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1351-1362
[6]   ARTICULAR MASTOCYTOSIS IN RHEUMATOID-ARTHRITIS [J].
CRISP, AJ ;
CHAPMAN, CM ;
KIRKHAM, SE ;
SCHILLER, AL ;
KRANE, SM .
ARTHRITIS AND RHEUMATISM, 1984, 27 (08) :845-851
[7]   Local expression of corticotropin releasing hormone in inflammatory arthritis [J].
Crofford, LJ ;
Sano, H ;
Karalis, K ;
Webster, EA ;
Friedman, TC ;
Chrousos, GP ;
Wilder, RL .
STRESS: BASIC MECHANISMS AND CLINICAL IMPLICATIONS, 1995, 771 :459-471
[8]  
CROFFORD LJ, 1993, J IMMUNOL, V151, P1
[9]   Human synovial mast cells .1. Ultrastructural in situ and in vitro immunologic characterization [J].
dePaulis, A ;
Marino, I ;
Ciccarelli, A ;
deCrescenzo, G ;
Concardi, M ;
Verga, L ;
Arbustini, E ;
Marone, G .
ARTHRITIS AND RHEUMATISM, 1996, 39 (07) :1222-1233
[10]   Human synovial mast cells .2. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs [J].
dePaulis, A ;
Ciccarelli, A ;
Marino, I ;
deCrescenzo, G ;
Marino, D ;
Marone, G .
ARTHRITIS AND RHEUMATISM, 1997, 40 (03) :469-478